1. Home
  2. AVBP vs PLAY Comparison

AVBP vs PLAY Comparison

Compare AVBP & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • PLAY
  • Stock Information
  • Founded
  • AVBP 2021
  • PLAY 1982
  • Country
  • AVBP United States
  • PLAY United States
  • Employees
  • AVBP N/A
  • PLAY N/A
  • Industry
  • AVBP
  • PLAY Restaurants
  • Sector
  • AVBP
  • PLAY Consumer Discretionary
  • Exchange
  • AVBP NYSE
  • PLAY Nasdaq
  • Market Cap
  • AVBP 705.8M
  • PLAY 678.9M
  • IPO Year
  • AVBP 2024
  • PLAY 1995
  • Fundamental
  • Price
  • AVBP $25.22
  • PLAY $32.77
  • Analyst Decision
  • AVBP Strong Buy
  • PLAY Hold
  • Analyst Count
  • AVBP 7
  • PLAY 8
  • Target Price
  • AVBP $39.29
  • PLAY $31.83
  • AVG Volume (30 Days)
  • AVBP 377.5K
  • PLAY 1.5M
  • Earning Date
  • AVBP 08-13-2025
  • PLAY 06-10-2025
  • Dividend Yield
  • AVBP N/A
  • PLAY N/A
  • EPS Growth
  • AVBP N/A
  • PLAY N/A
  • EPS
  • AVBP N/A
  • PLAY 1.02
  • Revenue
  • AVBP N/A
  • PLAY $2,112,300,000.00
  • Revenue This Year
  • AVBP $66.25
  • PLAY $3.62
  • Revenue Next Year
  • AVBP N/A
  • PLAY $6.33
  • P/E Ratio
  • AVBP N/A
  • PLAY $31.95
  • Revenue Growth
  • AVBP N/A
  • PLAY N/A
  • 52 Week Low
  • AVBP $15.47
  • PLAY $15.08
  • 52 Week High
  • AVBP $36.37
  • PLAY $43.73
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 67.19
  • PLAY 77.53
  • Support Level
  • AVBP $22.65
  • PLAY $31.44
  • Resistance Level
  • AVBP $25.80
  • PLAY $33.00
  • Average True Range (ATR)
  • AVBP 1.32
  • PLAY 1.62
  • MACD
  • AVBP 0.18
  • PLAY 0.79
  • Stochastic Oscillator
  • AVBP 87.89
  • PLAY 98.12

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About PLAY Dave & Buster's Entertainment Inc.

Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.

Share on Social Networks: